Glibornuride

Glibornuride is an oral, second-generation sulfonylurea medication used to treat type 2 diabetes mellitus. It lowers blood glucose levels by stimulating the pancreas to release insulin. It is generally prescribed for patients who still retain some residual pancreatic beta-cell function. It is grouped under the following drug class(es): Hypoglycemics and Sulfonylureas. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glutril and Glibornuridum. Its PubChem CID is 12818200.

CAS No 26944-48-9
Molecular Formula C18H26N2O4S
Molecular Weight 366.5 g/mol
Synonyms 1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea

Frequently Asked Questions